These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dissecting the Reduced Penetrance of Putative Loss-of-Function Variants in Population-Scale Biobanks. Blair DR; Risch N medRxiv; 2024 Oct; ():. PubMed ID: 39399029 [TBL] [Abstract][Full Text] [Related]
4. Transcript-Specific Loss-of-Function Variants in Park J; Reilaender A; Petry-Schmelzer JN; Stöbe P; Cordts I; Harmuth F; Rautenberg M; Woerz SE; Demidov G; Sturm M; Ossowski S; Schwaibold EMC; Wunderlich G; Paus S; Saft C; Haack TB Neurol Genet; 2022 Feb; 8(1):e644. PubMed ID: 34901436 [TBL] [Abstract][Full Text] [Related]
5. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype. Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087 [TBL] [Abstract][Full Text] [Related]
6. Population-Based Penetrance of Deleterious Clinical Variants. Forrest IS; Chaudhary K; Vy HMT; Petrazzini BO; Bafna S; Jordan DM; Rocheleau G; Loos RJF; Nadkarni GN; Cho JH; Do R JAMA; 2022 Jan; 327(4):350-359. PubMed ID: 35076666 [TBL] [Abstract][Full Text] [Related]
7. Biased pathogenic assertions of loss of function variants challenge molecular diagnosis of admixed individuals. Naslavsky MS; Scliar MO; Nunes K; Wang JYT; Yamamoto GL; Guio H; Tarazona-Santos E; Duarte YAO; Passos-Bueno MR; Meyer D; Zatz M Am J Med Genet C Semin Med Genet; 2021 Sep; 187(3):357-363. PubMed ID: 34189818 [TBL] [Abstract][Full Text] [Related]
9. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis. Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771 [TBL] [Abstract][Full Text] [Related]
10. Rare genetic variants in genes and loci linked to dominant monogenic developmental disorders cause milder related phenotypes in the general population. Kingdom R; Tuke M; Wood A; Beaumont RN; Frayling TM; Weedon MN; Wright CF Am J Hum Genet; 2022 Jul; 109(7):1308-1316. PubMed ID: 35700724 [TBL] [Abstract][Full Text] [Related]
11. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19. Povysil G; Butler-Laporte G; Shang N; Wang C; Khan A; Alaamery M; Nakanishi T; Zhou S; Forgetta V; Eveleigh RJ; Bourgey M; Aziz N; Jones SJ; Knoppers B; Scherer SW; Strug LJ; Lepage P; Ragoussis J; Bourque G; Alghamdi J; Aljawini N; Albes N; Al-Afghani HM; Alghamdi B; Almutairi MS; Mahmoud ES; Abu-Safieh L; El Bardisy H; Harthi FSA; Alshareef A; Suliman BA; Alqahtani SA; Almalik A; Alrashed MM; Massadeh S; Mooser V; Lathrop M; Fawzy M; Arabi YM; Mbarek H; Saad C; Al-Muftah W; Jung J; Mangul S; Badji R; Thani AA; Ismail SI; Gharavi AG; Abedalthagafi MS; Richards JB; Goldstein DB; Kiryluk K J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34043590 [TBL] [Abstract][Full Text] [Related]
12. A genome-first approach to rare variants in hypertrophic cardiomyopathy genes MYBPC3 and MYH7 in a medical biobank. Park J; Packard EA; Levin MG; Judy RL; ; Damrauer SM; Day SM; Ritchie MD; Rader DJ Hum Mol Genet; 2022 Mar; 31(5):827-837. PubMed ID: 34542152 [TBL] [Abstract][Full Text] [Related]
13. A deep catalogue of protein-coding variation in 983,578 individuals. Sun KY; Bai X; Chen S; Bao S; Zhang C; Kapoor M; Backman J; Joseph T; Maxwell E; Mitra G; Gorovits A; Mansfield A; Boutkov B; Gokhale S; Habegger L; Marcketta A; Locke AE; Ganel L; Hawes A; Kessler MD; Sharma D; Staples J; Bovijn J; Gelfman S; Di Gioia A; Rajagopal VM; Lopez A; Varela JR; Alegre-Díaz J; Berumen J; Tapia-Conyer R; Kuri-Morales P; Torres J; Emberson J; Collins R; ; ; Cantor M; Thornton T; Kang HM; Overton JD; Shuldiner AR; Cremona ML; Nafde M; Baras A; Abecasis G; Marchini J; Reid JG; Salerno W; Balasubramanian S Nature; 2024 Jul; 631(8021):583-592. PubMed ID: 38768635 [TBL] [Abstract][Full Text] [Related]
14. Metabolites downstream of predicted loss-of-function variants inform relationship to disease. Li M; Wang A; Quek LE; Vernon S; Figtree GA; Yang J; O'Sullivan JF Mol Genet Metab; 2019 Dec; 128(4):476-482. PubMed ID: 31679996 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the ExAC data set for the presence of individuals with pathogenic genotypes implicated in severe Mendelian pediatric disorders. Tarailo-Graovac M; Zhu JYA; Matthews A; van Karnebeek CDM; Wasserman WW Genet Med; 2017 Dec; 19(12):1300-1308. PubMed ID: 28471432 [TBL] [Abstract][Full Text] [Related]
16. Exome sequencing and characterization of 49,960 individuals in the UK Biobank. Van Hout CV; Tachmazidou I; Backman JD; Hoffman JD; Liu D; Pandey AK; Gonzaga-Jauregui C; Khalid S; Ye B; Banerjee N; Li AH; O'Dushlaine C; Marcketta A; Staples J; Schurmann C; Hawes A; Maxwell E; Barnard L; Lopez A; Penn J; Habegger L; Blumenfeld AL; Bai X; O'Keeffe S; Yadav A; Praveen K; Jones M; Salerno WJ; Chung WK; Surakka I; Willer CJ; Hveem K; Leader JB; Carey DJ; Ledbetter DH; ; Cardon L; Yancopoulos GD; Economides A; Coppola G; Shuldiner AR; Balasubramanian S; Cantor M; ; Nelson MR; Whittaker J; Reid JG; Marchini J; Overton JD; Scott RA; Abecasis GR; Yerges-Armstrong L; Baras A Nature; 2020 Oct; 586(7831):749-756. PubMed ID: 33087929 [TBL] [Abstract][Full Text] [Related]
17. Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study. Fewings E; Larionov A; Redman J; Goldgraben MA; Scarth J; Richardson S; Brewer C; Davidson R; Ellis I; Evans DG; Halliday D; Izatt L; Marks P; McConnell V; Verbist L; Mayes R; Clark GR; Hadfield J; Chin SF; Teixeira MR; Giger OT; Hardwick R; di Pietro M; O'Donovan M; Pharoah P; Caldas C; Fitzgerald RC; Tischkowitz M Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):489-498. PubMed ID: 29706558 [TBL] [Abstract][Full Text] [Related]
18. Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting. Wright CF; West B; Tuke M; Jones SE; Patel K; Laver TW; Beaumont RN; Tyrrell J; Wood AR; Frayling TM; Hattersley AT; Weedon MN Am J Hum Genet; 2019 Feb; 104(2):275-286. PubMed ID: 30665703 [TBL] [Abstract][Full Text] [Related]
19. Failure to replicate the association of rare loss-of-function variants in type I IFN immunity genes with severe COVID-19. Povysil G; Butler-Laporte G; Shang N; Weng C; Khan A; Alaamery M; Nakanishi T; Zhou S; Forgetta V; Eveleigh R; Bourgey M; Aziz N; Jones S; Knoppers B; Scherer S; Strug L; Lepage P; Ragoussis J; Bourque G; Alghamdi J; Aljawini N; Albes N; Al-Afghani HM; Alghamdi B; Almutair M; Mahmoud ES; Safie LA; Bardisy HE; Al Harthi FS; Alshareef A; Suliman BA; Alqahtani S; AlMalik A; Alrashed MM; Massadeh S; Mooser V; Lathrop M; Arabi Y; Mbarek H; Saad C; Al-Muftah W; Badji R; Al Thani A; Ismail SI; Gharavi AG; Abedalthagafi MS; Richards JB; Goldstein DB; Kiryluk K medRxiv; 2020 Dec; ():. PubMed ID: 33398295 [TBL] [Abstract][Full Text] [Related]
20. Frequency and Phenotype Associations of Rare Variants in 5 Monogenic Cerebral Small Vessel Disease Genes in 200,000 UK Biobank Participants. Ferguson AC; Thrippleton S; Henshall D; Whittaker E; Conway B; MacLeod M; Malik R; Rawlik K; Tenesa A; Sudlow C; Rannikmae K Neurol Genet; 2022 Oct; 8(5):e200015. PubMed ID: 36035235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]